Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kukjeon Pharmaceutical Co Ltd
Total Current Assets
Kukjeon Pharmaceutical Co Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
|
Total Current Assets
₩96.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
138%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Total Current Assets
₩1.5T
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Current Assets
₩683.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Current Assets
₩893.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Current Assets
₩241.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Total Current Assets
₩83.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Kukjeon Pharmaceutical Co Ltd
Glance View
Kukjeon Pharmaceutical Co., Ltd. engages in providing financial support services. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2018-12-19. The firm manufactures and sells raw materials used in specialized medicines such as choline alfoscerates, benfothiamines, spherical sorbents, and napamostat mesylatse. The firm sells its products in domestic and overseas markets such as Japan.
See Also
What is Kukjeon Pharmaceutical Co Ltd's Total Current Assets?
Total Current Assets
96.2B
KRW
Based on the financial report for Sep 30, 2025, Kukjeon Pharmaceutical Co Ltd's Total Current Assets amounts to 96.2B KRW.
What is Kukjeon Pharmaceutical Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
138%
Over the last year, the Total Current Assets growth was -25%. The average annual Total Current Assets growth rates for Kukjeon Pharmaceutical Co Ltd have been -16% over the past three years , 138% over the past five years .
